Sponsors (22)
The bill directs coordinated VA–DoD research and evidence-based clinical guidance to improve diagnosis, care, and claims decisions for veterans with blast exposure, but it requires federal resources and risks budgetary pressure and limited long-term continuity unless sustained funding or follow-on programs are provided.
Veterans and service members with blast exposure will receive better-tailored care and benefits through coordinated VA–DoD research and clinical guidance.
Patients (especially veterans) with long-term blast-related conditions will have faster access to potential new diagnostics and treatments because the bill prioritizes translational research (sleep therapy, gut health, mobile diagnostics, vestibular/autonomic dysregulation, neuroinflammation, cumulative mTBI).
Veterans filing claims will benefit from faster and more standardized benefits decisions because claims processors and examiners receive evidence-based recommendations.
Veterans and taxpayers could face strained VA budgets and longer wait times if recommendations lead to increased benefits payouts that are not matched with additional funding.
Taxpayers and federal employees will incur administrative and coordination costs to establish and operate the temporary Task Force and related research activities.
Veterans, military personnel, and the research community risk losing long-term oversight and research momentum because the Task Force sunsets in 2029 unless follow-on programs are created.
Based on analysis of 2 sections of legislative text.
Requires the VA (via the VA–DoD Joint Executive Committee) to create a time‑limited task force to coordinate blast overpressure research, baselines, diagnostics, and annual reports through Sept 30, 2029.
Introduced December 4, 2025 by Ronny Jackson · Last progress December 4, 2025
Requires the Department of Veterans Affairs, working through the VA–DoD Joint Executive Committee, to establish a time-limited Blast Overpressure Task Force within 180 days to coordinate research, clinical baselines, diagnostics, and care improvements for veterans and service members affected by blast overpressure or exposure. The Task Force must set research priorities, align VA and DoD strategies, monitor sensory and stress-related impairments, integrate mobile and longitudinal diagnostic tools, and report annually to congressional veterans and armed services committees. The Task Force must recommend improvements to VA claims evaluation and neurological exam practices, prioritize translational research areas (for example sleep therapy, gut health, vestibular dysfunction, autonomic dysregulation, cumulative mild TBI, and neuroinflammation), and will sunset on September 30, 2029.